Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Person › Details

Julia Wilson (JW Communications Ltd.)

Wilson, Julia (Achilles Therapeutics 202011 Head of Communications + JW Communications 201209– before Vectura Group)

	Organisation	JW Communications Ltd.
	Former/major organisation	Vectura Group plc (LSE: VEC)
	Group	Vectura (Group)
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

Record changed: 2024-03-01

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Julia Wilson

[1] Achilles Therapeutics Ltd.. (11/19/20). "Press Release: Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours". Stevenage....
[2] Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London....
[3] Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London....
[4] OMass Technologies Ltd.. (7/11/18). "Press Release: OMass Technologies Announces Publication Demonstrating the Impact of Lipid Interactions on GPCR Signalling in Nature". Oxford....
[5] Autolus Therapeutics plc. (6/26/18). "Press Release: Autolus Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". London....
[6] Autolus Therapeutics plc. (6/22/18). "Press Release: Autolus Announces Pricing of Initial Public Offering". London....
[7] Autolus Therapeutics Ltd.. (6/8/18). "Press Release: Autolus Launches Roadshow for Initial Public Offering". London....
[8] Autolus Therapeutics Ltd.. (5/8/18). "Press Release: Autolus Files for Proposed Initial Public Offering in the United States". London....
[9] Autolus Therapeutics Ltd.. (3/5/18). "Press Release: Autolus Announces Confidential Submission of Draft Registration Statement for Potential Initial Public Offering in the United States". London....
[10] Autolus Therapeutics Ltd.. (1/2/18). "Press Release: Publication of Pre-clinical Data of a Dual Targeting CAR for Treatment of Multiple Myeloma". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]